MH
Meihua International Medical Technologies Co., Ltd.
MHUA · NASDAQ
$2.75 -9.84% (-$0.30)
Market Cap $871.0K
P/E Ratio 0.27x
Div. Yield -
ROE 10.49%
Bulios Fair Price
$3.72
35.3% upside
Current Price
$2.75
Undervalued Fair Value Overvalued
According to Bulios Fair Price, MHUA is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
4/9Valuation
100 /100
Cheap P/S 0.01x
P/B 0.01x
P/FCF 0.17x
Growth
43 /100
Stable Rev. growth 9.08%
Book val. growth 32.29%
EPS growth 25.00%
Profitability
50 /100
Moderate Net margin 10.37%
Op. margin 13.01%
FCF margin 3.23%
Quality
57 /100
Average ROE 10.49%
ROA 8.58%
Asset turnover 0.83x
Debt
100 /100
Low Current ratio 5.71x
Int. coverage 42.04x
Net debt/EBITDA -0.18x
Stability
80 /100
Stable Rev. volatility 9.01%
EPS volatility 50.93%
Profitable years 6
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about MHUA
Online
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Lee Leyi
Employees
619
Headquarters
Yangzhou